GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a major focus in medical research, largely due to its notable impact on controlling conditions such as type 2 diabetes and obesity. Ongoing trials have demonstrated that in addition to glucose management, GLP-1 medications offer benefits for cardiovascular function an